End-of-day quote
Korea S.E.
06:00:00 2024-05-23 pm EDT
|
5-day change
|
1st Jan Change
|
11,250
KRW
|
-1.14%
|
|
+4.26%
|
+22.55%
|
Apr. 26 |
ICD Co., Ltd. announced that it has received KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Kiwoomfni Co., Ltd., Shinhan Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd.
|
CI
| Apr. 25 |
Lunit Inc. announced that it expects to receive KRW 171.5 billion in funding from a group of investors
|
CI
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
86,936
|
99,919
|
117,357
|
199,838
|
104,501
|
116,848
|
Enterprise Value (EV)
1 |
-493,878
|
-438,191
|
-311,929
|
-193,165
|
-129,132
|
-235,606
|
P/E ratio
|
19.3
x
|
4.55
x
|
2.57
x
|
2.53
x
|
4.42
x
|
3.37
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.46
x
|
0.35
x
|
0.25
x
|
0.23
x
|
0.1
x
|
0.13
x
|
EV / Revenue
|
-2.62
x
|
-1.52
x
|
-0.68
x
|
-0.22
x
|
-0.12
x
|
-0.26
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
0.33
x
|
0.34
x
|
0.34
x
|
0.47
x
|
0.23
x
|
0.24
x
|
Nbr of stocks (in thousands)
|
12,729
|
12,729
|
12,729
|
12,729
|
12,729
|
12,729
|
Reference price
2 |
6,830
|
7,850
|
9,220
|
15,700
|
8,210
|
9,180
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
188,678
|
288,165
|
461,026
|
864,348
|
1,090,081
|
919,711
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
6,303
|
29,003
|
65,119
|
114,194
|
35,532
|
46,935
|
Net income
1 |
4,654
|
22,161
|
45,930
|
79,444
|
24,033
|
35,104
|
Net margin
|
2.47%
|
7.69%
|
9.96%
|
9.19%
|
2.2%
|
3.82%
|
EPS
2 |
354.5
|
1,726
|
3,583
|
6,206
|
1,858
|
2,728
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2023 Q1
|
---|
Net sales
1 |
224.1
|
216.6
|
50.7
|
-
|
39.27
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
24.94
|
19.43
|
20.85
|
-
|
16.09
|
Operating Margin
|
11.13%
|
8.97%
|
41.12%
|
-
|
40.98%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
8.04
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
632.0
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/12/21
|
1/28/22
|
5/16/22
|
8/16/22
|
5/15/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
580,814
|
538,110
|
429,286
|
393,003
|
233,633
|
352,454
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
1.73%
|
7.85%
|
14.2%
|
20.3%
|
5.39%
|
7.4%
|
ROA (Net income/ Total Assets)
|
0.26%
|
1.21%
|
2.42%
|
4.41%
|
1.53%
|
2.16%
|
Assets
1 |
1,781,257
|
1,833,476
|
1,894,947
|
1,800,584
|
1,568,242
|
1,625,419
|
Book Value Per Share
2 |
20,994
|
22,947
|
27,375
|
33,760
|
35,885
|
38,274
|
Cash Flow per Share
2 |
196.0
|
264.0
|
8,649
|
8,100
|
10,379
|
12,103
|
Capex
1 |
2,050
|
5,817
|
1,681
|
2,494
|
2,146
|
447
|
Capex / Sales
|
1.09%
|
2.02%
|
0.36%
|
0.29%
|
0.2%
|
0.05%
|
Announcement Date
|
3/1/19
|
2/29/20
|
3/1/21
|
3/1/22
|
3/1/23
|
2/29/24
|
|
1st Jan change
|
Capi.
|
---|
| +22.55% | 106M | | -14.65% | 33.6B | | -13.55% | 12.59B | | +3.76% | 9.36B | | +13.18% | 9.2B | | +18.93% | 4.04B | | +3.12% | 3.99B | | +22.03% | 3.28B | | -2.36% | 2.9B | | +1.21% | 2.84B |
Investment Banking
|